Calcium-activated chloride channels: (un)known, (un)loved?

Area of Science:

• Physiology
• Molecular Biology
• Channelopathies

Background:

• Calcium-activated chloride channels (CaCCs) are crucial for physiological functions including epithelial transport and cellular excitability.
• In airways, CaCCs are essential for maintaining proper epithelial fluid secretion.
• Dysfunction of CaCCs is implicated in various diseases, highlighting the need for better understanding.

Purpose of the Study:

• To review the current understanding and unresolved questions regarding the molecular identity of CaCCs.
• To discuss the limitations of existing pharmacological tools for CaCC manipulation.
• To explore the potential of CaCCs as therapeutic targets, particularly for cystic fibrosis.

Main Methods:

• Review of existing literature on CaCCs, focusing on biophysical properties, molecular candidates, and pharmacological agents.
• Analysis of studies investigating CLCA and bestrophin families as potential CaCCs.
• Discussion of challenges in CaCC research and therapeutic development.

Main Results:

• The molecular identity of CaCCs remains unresolved, with conflicting evidence for CLCA proteins and emerging data on bestrophins.
• Existing pharmacological tools for modulating CaCCs lack specificity, hindering research and therapeutic applications.
• Potential challenges exist for targeting CaCCs in cystic fibrosis therapy.

Conclusions:

• Further research is needed to definitively identify the molecular components of CaCCs.
• Development of selective pharmacological agents is critical for advancing CaCC research and therapeutic strategies.
• Careful consideration of potential pitfalls is necessary when developing CaCC-targeted therapies for diseases like cystic fibrosis.